Triplixam
Brand Name: Triplixam
Generic Name: Perindopril Arginine + Indapamide + Amlodipine (as besilate)
Expiring Soon
Registration Number
DR-XY44976
Dosage Form
Film-Coated Tablet
Issuance Date
April 29, 2022
Expiry Date
December 29, 2025
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg/ 1.25 mg/ 5 mg
PackagingOpaque White Polypropylene bottle with LDPE plug
containing desiccant x 30's (Box of 30 tablets)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antihypertensive (ACE Inhibitor-Diuretic-Calcium
Channel Blocker Combination)
A
Application
Initial (from Monitored Release status) :
Philippine FDA Classification
Active Ingredients (3)
Complete list of active ingredients in this pharmaceutical product.
Perindopril ArginineActive
Monograph: Perindopril
IndapamideActive
Monograph: Indapamide
Amlodipine (as
besilate)Active
Monograph: amlodipine nicotinate